[1] |
LIU J,LIANG W,JING W,et al.Countdown to 2030:eliminating hepatitis B disease,China[J]. Bull World Health Organ,2019,97(3):230-238.
|
[2] |
MACLACHLAN J H,LOCARNINI S,COWIE B C.Estimating the global prevalence of hepatitis B[J]. Lancet,2015,386(10003):1515-1517.
|
[3] |
LOZANO R,NAGHAVI M,FOREMAN K,et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet,2012,380(9859):2095-2128.
|
[4] |
ROMANELLI R G,STASI C.Recent advancements in diagnosis and therapy of liver cirrhosis[J]. Curr Drug Targets,2016,17(15):1804-1817.
|
[5] |
王贵强,王福生,庄辉,等. 慢性乙型肝炎防治指南(2019年版)[J]. 中华实验和临床感染病杂志(电子版),2019,13(6):441-466.
|
[6] |
BUDHU A,WANG X W.The role of cytokines in hepatocellular carcinoma[J]. J Leukoc Biol,2006,80(6):1197-1213.
|
[7] |
TSUCHIDA T,FRIEDMAN S L.Mechanisms of hepatic stellate cell activation[J]. Nat Rev Gastroenterol Hepatol,2017,14(7):397-411.
|
[8] |
LIPPI G,DIPALO M,TETI L,et al.Relationship between red blood cell distribution width and prognostic biomarkers in patients admitted to the emergency department with acute infections[J]. Eur J Intern Med,2013,24(2):e15-e16.
|
[9] |
YANG J,YAN B,YANG L,et al.Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis:a retrospective cross-sectional study[J]. BMC Gastroenterol,2018,18(1):161.
|
[10] |
ROCCO A,COMPARE D,COCCOLI P,et al.Vitamin B12 supplementation improves rates of sustained viral response in patients chronically infected with hepatitis C virus[J]. Gut,2013,62(5):766-773.
|
[11] |
VAN ZWIETEN R,BOCHEM A E,HILARIUS P M,et al.The cholesterol content of the erythrocyte membrane is an important determinant of phosphatidylserine exposure[J]. Biochim Biophys Acta,2012,1821(12):1493-1500.
|
[12] |
WEISS G,GOODNOUGH L T.Anemia of chronic disease[J]. N Engl J Med,2005,352(10):1011-1023.
|
[13] |
GONZALEZ-CASAS R,JONES E A,MORENO-OTERO R.Spectrum of anemia associated with chronic liver disease[J]. World J Gastroenterol,2009,15(37):4653-4658.
|
[14] |
SUN L,YE R D.Serum amyloid A1:structure,function and gene polymorphism[J]. Gene,2016,583(1):48-57.
|
[15] |
ANTHONY D,SEOW H J,UDDIN M,et al.Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and γδ T cells[J]. Am J Respir Crit Care Med,2013,188(2):179-186.
|
[16] |
SACK GH Jr.Serum amyloid A - a review[J]. Mol Med,2018,24(1):46.
|
[17] |
BIOULAC-SAGE P,REBOUISSOU S,THOMAS C,et al.Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry[J]. Hepatology,2007,46(3):740-748.
|
[18] |
LAN F,WEI H,ZHU X,et al.Increased red cell distribution width is strong inflammatory marker of liver diseases in a guangxi population[J]. Clin Lab,2017,63(2):389-398.
|
[19] |
MICHAELI A,FINCI-YEHESKEL Z,DISHON S,et al.Serum amyloid A enhances plasminogen activation:implication for a role in colon cancer[J]. Biochem Biophys Res Commun,2008,368(2):368-373.
|
[20] |
DOWLING P,CLARKE C,HENNESSY K,et al.Analysis of acute-phase proteins,AHSG,C3,CLI,HP and SAA,reveals distinctive expression patterns associated with breast,colorectal and lung cancer[J]. Int J Cancer,2012,131(4):911-923.
|